GO:0048763 calcium-induced calcium release activity

Calcium ions are universal second messengers that control a vast array of cellular processes, from muscle contraction to gene transcription. A fundamental mechanism by which cells amplify and shape calcium signals is calcium-induced calcium release (CICR), formally annotated as GO:0048763 calcium-induced calcium release activity. This molecular function enables the transmembrane transfer of calcium ions from an intracellular store to the cytosol when the cytosolic calcium concentration rises. First described in cardiac muscle, CICR is now recognized as a widespread signaling principle in excitable and non-excitable cells. In cardiomyocytes, a small influx of calcium through voltage-gated L-type calcium channels triggers a much larger release of calcium from the sarcoplasmic reticulum through ryanodine receptor 2 (RYR2), a process essential for excitation-contraction coupling. Similarly, in skeletal muscle, depolarization of the transverse tubule activates ryanodine receptor 1 (RYR1), leading to calcium release from the sarcoplasmic reticulum and muscle contraction. Beyond muscle, CICR operates in neurons, where it contributes to synaptic plasticity, neuronal development, and pathophysiological states such as epilepsy and neurodegeneration. In noradrenergic neurons of the locus coeruleus, CICR modulates excitability and neurotransmitter release. In hypothalamic oxytocinergic neurons, dendritic osmosensors modulate activity-induced calcium influx, highlighting the integration of CICR with sensory inputs. Even in invertebrates, such as Caenorhabditis elegans body muscles, voltage-induced calcium release shares molecular features with vertebrate CICR. Understanding the molecular players and regulatory mechanisms of CICR is therefore critical for deciphering calcium signaling in health and disease. This article provides a research-grade overview of GO:0048763, covering its definition, mechanism, key genes, disease relevance, and state-of-the-art methods for investigation, including CRISPR-based models offered by EDITGENE.

GO:0048763 calcium-induced calcium release activity is a molecular function term defined in the Gene Ontology as enabling the transmembrane transfer of calcium ions from an intracellular store to the cytosol on induction by increased calcium concentration. In simpler terms, it is the ability of a cell to release calcium from internal stores (such as the endoplasmic reticulum or sarcoplasmic reticulum) in response to a rise in cytosolic calcium, thereby amplifying the initial calcium signal. This function is typically mediated by calcium-sensitive calcium channels, such as ryanodine receptors, which open when they bind calcium ions, allowing a positive feedback loop of calcium release.

Calcium-induced calcium release activity is a fundamental signaling mechanism that converts a small calcium stimulus into a large, regenerative calcium wave. This amplification is essential for rapid and efficient cellular responses, such as muscle contraction and neurotransmitter release. In the heart, CICR ensures that each action potential triggers a robust calcium transient that drives contraction, and defects in this process lead to arrhythmias and heart failure. In skeletal muscle, CICR is required for excitation-contraction coupling, and mutations in RYR1 cause malignant hyperthermia and central core disease. In the nervous system, CICR contributes to synaptic plasticity, learning, and memory, and its dysregulation is implicated in Alzheimer's disease and other neurodegenerative conditions. Moreover, CICR is involved in gene expression regulation, cell proliferation, and apoptosis, making it relevant to cancer biology. Given its broad physiological and pathological significance, understanding the molecular components and regulatory mechanisms of CICR is a major research focus, and CRISPR-based models are invaluable for dissecting gene function in this context.

The following genes encode proteins that are directly involved in calcium-induced calcium release activity, including calcium release channels, voltage-gated calcium channels, and their regulatory subunits.

Calcium-induced calcium release activity is tightly regulated at multiple levels. At the channel level, ryanodine receptors are modulated by calcium itself, with high concentrations inhibiting the channel to prevent excessive release. Accessory proteins such as calstabin (FKBP12/12.6) stabilize the closed state, and their dissociation due to phosphorylation by PKA or CaMKII can cause pathological calcium leak. In skeletal muscle, the interaction between the dihydropyridine receptor and RYR1 is essential for voltage-induced calcium release, and this coupling is regulated by intracellular calcium and magnesium. In neurons, CICR is modulated by signaling pathways involving IP3 receptors, which can be activated by G-protein-coupled receptors, and by calcium-binding proteins such as calmodulin. Additionally, in C. elegans body muscles, voltage-induced calcium release is regulated by the EGL-19 calcium channel and the UNC-68 ryanodine receptor, providing a genetic model for studying CICR regulation. Post-translational modifications, including phosphorylation, oxidation, and nitrosylation, also influence RYR activity and thus CICR. These regulatory mechanisms ensure that calcium release is appropriate to the cellular context and prevent pathological calcium overload.

Dysregulation of calcium-induced calcium release in cardiomyocytes is a hallmark of cardiac arrhythmias and heart failure. Mutations in RYR2, the cardiac ryanodine receptor, cause catecholaminergic polymorphic ventricular tachycardia (CPVT), a disorder characterized by stress-induced ventricular arrhythmias. In heart failure, hyperphosphorylation of RYR2 by PKA leads to dissociation of calstabin2, resulting in diastolic calcium leak that depletes sarcoplasmic reticulum calcium stores and impairs contractility. Similarly, mutations in calmodulin (CALM1, CALM2, CALM3) can alter RYR2 regulation and cause long QT syndrome and CPVT. These findings highlight CICR as a central node in cardiac pathology and a target for therapeutic intervention.

In skeletal muscle, mutations in RYR1 are linked to malignant hyperthermia, a life-threatening reaction to volatile anesthetics, and central core disease, a congenital myopathy. These mutations often increase the sensitivity of RYR1 to activation by calcium or other triggers, leading to excessive calcium release and muscle hypermetabolism. Additionally, mutations in CACNA1S, the skeletal muscle dihydropyridine receptor, can cause hypokalemic periodic paralysis and malignant hyperthermia susceptibility. Dysregulation of CICR in skeletal muscle thus has severe clinical consequences, and understanding the molecular basis is critical for diagnosis and treatment.

In neurons, calcium-induced calcium release contributes to synaptic plasticity, but its dysregulation is implicated in neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. Excessive calcium release from the endoplasmic reticulum via ryanodine receptors can lead to calcium overload, mitochondrial dysfunction, and apoptosis. In noradrenergic neurons of the locus coeruleus, CICR modulates excitability and may contribute to stress-related disorders. Furthermore, in hypothalamic oxytocinergic neurons, dendritic osmosensors modulate activity-induced calcium influx, and disruption of this process may affect osmotic homeostasis. These findings suggest that CICR is a potential therapeutic target for neuroprotection.

Calcium-induced calcium release activity has been implicated in cancer cell proliferation, migration, and apoptosis. Altered expression of ryanodine receptors and other CICR components has been observed in various cancers, and calcium signaling remodeling is a hallmark of oncogenesis. For example, RYR1 and RYR2 expression is altered in breast and prostate cancer, and modulation of CICR can affect cell cycle progression. Although the exact mechanisms are still being elucidated, targeting CICR pathways may offer novel strategies for cancer therapy.

Calcium imaging using fluorescent indicators such as Fura-2, Fluo-4, or genetically encoded calcium indicators (GCaMP) is the primary method to measure calcium-induced calcium release activity in live cells. In cardiomyocytes, caffeine-induced calcium release is used to assess sarcoplasmic reticulum calcium content, while field stimulation or voltage-clamp triggers CICR. In neurons, two-photon calcium imaging allows visualization of calcium transients in dendrites and spines. These techniques provide spatial and temporal resolution of calcium signals and can be combined with pharmacological inhibitors to dissect specific pathways.

Patch-clamp electrophysiology is used to measure calcium currents through voltage-gated calcium channels and to study the coupling between calcium influx and ryanodine receptor activation. In cardiac myocytes, simultaneous recording of L-type calcium currents and calcium transients reveals the efficiency of CICR. In skeletal muscle, voltage-clamp of the transverse tubule can assess the mechanical coupling between the dihydropyridine receptor and RYR1. These methods provide quantitative insights into the biophysical properties of CICR.

Genetically encoded calcium indicators (GECIs) such as GCaMP can be targeted to specific cell types or subcellular compartments to monitor CICR in vivo. For example, GCaMP expressed in cardiomyocytes allows real-time monitoring of calcium transients in beating hearts. Similarly, targeted probes like D1ER or D4ER can measure endoplasmic reticulum calcium concentrations. These tools enable longitudinal studies of CICR in intact organisms and disease models.

CRISPR-based loss-of-function screens can identify genes that regulate calcium-induced calcium release activity. For instance, a genome-wide CRISPR knockout screen in a calcium reporter cell line can uncover novel modulators of CICR. Similarly, CRISPR activation (CRISPRa) screens can identify genes whose overexpression enhances or suppresses CICR. These approaches are powerful for discovering new therapeutic targets and understanding the genetic network underlying calcium signaling.

Researchers studying calcium-induced calcium release activity-related genes often need to determine whether a candidate gene is causally involved in the process, how specific mutations alter channel function, and whether targeting the gene can modulate disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR-based services to address these questions, from generating knockout cell lines to creating precise point mutations and knock-in reporters.

Calcium-induced calcium release activity (GO:0048763) is a fundamental molecular function that amplifies calcium signals in excitable and non-excitable cells. Its roles in muscle contraction, neuronal plasticity, and hormone secretion are well established, and its dysregulation underlies a range of diseases, including cardiac arrhythmias, myopathies, and neurodegeneration. Understanding the molecular players and regulatory mechanisms of CICR is essential for developing targeted therapies. EDITGENE provides comprehensive CRISPR-based services, including knockout, point mutation, knock-in, overexpression, and library screening, to support research on CICR-related genes. By leveraging these tools, researchers can accelerate discoveries in calcium signaling and translate them into clinical applications.